Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Does anaesthesia in mothers during delivery affect bilirubin levels in their neonates?

  • El-Kabbany, Zeinab A (Department of Pediatrics, Faculty of Medicine, Ain-Shams University) ;
  • Toaima, Nadin N (Department of Pediatrics, Faculty of Medicine, Ain-Shams University) ;
  • Toaima, Tamer N (Department of Anaesthesiology and Intensive Care Unit, Faculty of Medicine, Ain-Shams University) ;
  • EL-Din, Mona Y Gamal (Ministry of Health Hospital)
  • Received : 2017.01.06
  • Accepted : 2017.04.11
  • Published : 2017.12.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study aimed to assess whether different anesthetic techniques and oxytocin use applied during delivery affect transcutaneous bilirubin levels during the first 24 hours in neonates. Methods: A total of 1,044 neonates delivered by either caesarian section (C/S) or normal vaginal delivery (NVD) were included in the study. They were classified into 5 groups as follows: group 1: born by C/S using general anesthesia, group 2: C/S using spinal anaesthesia, group 3: C/S using general anesthesia after failed spinal block, group 4: by NVD without anesthesia, and group 5: oxytocin-induced vaginal delivery without anesthesia. Transcutaneous total bilirubin levels (TBLs) were measured during the first 24 hours and on the fifth and eighth days of life and the levels in different groups were compared. Results: The TBLs were significantly higher in neonates delivered by C/S using general anesthesia rather than spinal anesthesia (P<0.001), and both groups had higher levels than those born by NVD without anesthesia ($P{\leq}0.001$). However, the group receiving general anesthesia after failed spinal block was found to have the highest bilirubin level. Moreover, TBLs were significantly higher with the use of oxytocin ($P{\leq}0.001$). Conclusions: C/S and general anesthesia adversely affect the bilirubin levels in neonates, and the use of oxytocin during vaginal delivery also increases TBLs in neonates.

Keywords

References

  1. Chowdhury AD, Hussey MH, Shortland DB. Critical overview of the management of neonatal jaundice in the UK. Public Health 2007;121:137-43. https://doi.org/10.1016/j.puhe.2006.07.030
  2. Amin SB, Lamola AA. Newborn jaundice technologies: unbound bilirubin and bilirubin binding capacity in neonates. Semin Perinatol 2011;35:134-40. https://doi.org/10.1053/j.semperi.2011.02.007
  3. Petrova A, Mehta R, Birchwood G, Ostfeld B, Hegyi T. Management of neonatal hyperbilirubinemia: pediatricians' practices and educational needs. BMC Pediatr 2006;6:6. https://doi.org/10.1186/1471-2431-6-6
  4. Oral E, Gezer A, Cagdas A, Pakkal N. Oxytocin infusion in labor: the effect different indications and the use of different diluents on neonatal bilirubin levels. Arch Gynecol Obstet 2003;267:117-20. https://doi.org/10.1007/s00404-002-0298-3
  5. Gavinelli R, Vignolo Lutati C, Galletto P. Drugs administered to the mother during labor and neonatal jaundice. Pediatr Med Chir 1982;4:525-9.
  6. De Amici D, Delmonte P, Martinotti L, Gasparoni A, Zizzi S, Ramajoli I, et al. Can anesthesiologic strategies for caesarean section influence newborn jaundice? A retrospective and prospective study. Biol Neonate 2001;79:97-102. https://doi.org/10.1159/000047074
  7. Ozcakir HT, Lacin S, Baytur YB, Luleci N, Inceboz US. Different anesthesiologic strategies have no effect on neonatal jaundice. Arch Gynecol Obstet 2004;270:179-81. https://doi.org/10.1007/s00404-003-0580-z
  8. Rehman HU. Methemoglobinemia. West J Med 2001;175:193-6. https://doi.org/10.1136/ewjm.175.3.193
  9. Sima DG, Neligan GA. Factors affecting the increasing incidence of severe non-haemolytic neonatal jaundice. Br J Obstet Gynaecol 1975;82:863-7. https://doi.org/10.1111/j.1471-0528.1975.tb00590.x
  10. Alkan S, Tiras U, Dallar Y, Sunay D. Effect of anaesthetic agents administered to the mothers on transcutaneous bilirubin levels in the neonates. Acta Paediatr 2010;99:993-6. https://doi.org/10.1111/j.1651-2227.2010.01761.x
  11. Demiraran Y, Albayrak M, Seker IS, Kaynak G, Iskender A, Sezen GY, et al. Effect of anesthesiological strategies on neonatal bilirubin levels during cesarean section: a prospective and randomized trial. Arch Gynecol Obstet 2011;284:1059-65. https://doi.org/10.1007/s00404-010-1783-8
  12. Gale R, Seidman DS, Dollberg S, Stevenson DK. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr 1990;10:82-6. https://doi.org/10.1097/00005176-199001000-00016
  13. Eskicioglu F, Ozlem S, Bilgili G, Baytur Y. Evaluation of the effects of different anesthetic techniques on neonatal bilirubin levels. Int J Women Health Reprod Sci 2014;2:124-30.
  14. Osborn LM, Reiff MI, Bolus R. Jaundice in the full-term neonate. Pediatrics 1984;73:520-5.
  15. Phuapradit W, Chaturachinda K, Auntlamai S. Risk factors for neonatal hyperbilirubinemia. J Med Assoc Thai 1993;76:424-8.
  16. Chen TL, Wu CH, Chen TG, Tai YT, Chang HC, Lin CJ. Effects of propofol on functional activities of hepatic and extrahepatic conjugation enzyme systems. Br J Anaesth 2000;84:771-6. https://doi.org/10.1093/oxfordjournals.bja.a013592
  17. Clark DA, Landaw SA. Bupivacaine alters red blood cell properties: a possible explanation for neonatal jaundice associated with maternal anesthesia. Pediatr Res 1985;19:341-3. https://doi.org/10.1203/00006450-198519040-00004
  18. McLeod GA, Gennery BA, Brennan NE. Levobupivacaine: improved safety for obstetric anesthesia. Adv Anaesth 2001;18:55-89.